Contact
searchSearch
HMP Global

Osteoarthritis Case Report

Case Report
Intra-Articular Steroids for a Patient With Osteoarthritis Knee Pain: Risks and Benefits
07/31/2019
Authors: Eric A. Dietrich, PharmD, BCPS, and Kyle Davis, PharmD, BCPS Citation: Dietrich EA, Davis K. Intra-articular steroids for a patient with osteoarthritis knee pain: risks and benefits. Consultant....
Authors: Eric A. Dietrich, PharmD, BCPS, and Kyle Davis, PharmD, BCPS Citation: Dietrich EA, Davis K. Intra-articular steroids for a patient with osteoarthritis knee pain: risks and benefits. Consultant....
...
07/31/2019
Rheumatology & Arthritis
Case Report
The Potential Risks and Benefits Associated With the Use of Celecoxib and Other NSAIDs
02/07/2017
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for the treatment of mild to moderate pain. Ibuprofen and naproxen are available over-the-counter (OTC) and are commonly used by patients; as such, patients may not report their...
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for the treatment of mild to moderate pain. Ibuprofen and naproxen are available over-the-counter (OTC) and are commonly used by patients; as such, patients may not report their...
Nonsteroidal anti-inflammatory...
02/07/2017
Rheumatology & Arthritis

Popular Articles

News
Nearly All Patients in AxSpA Remission Flare After TNFi Tapering
03/18/2024

Jolynn Tumolo

Jolynn Tumolo
More than half maintained remission until the dose was dropped to 1/3 or less of their starting dosage.
More than half maintained remission until the dose was dropped to 1/3 or less of their starting dosage.
More than half maintained...
03/18/2024
Rheumatology & Arthritis
News
No Major Risk of CVD Events With JAKs or bDMARDs in RA
08/23/2024
Jessica Garlewicz
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
A recent study found no...
08/23/2024
Rheumatology & Arthritis
News
Relations Between Clinical Response Criteria and Disease Activity Levels With Axial Spondyloarthritis
05/14/2024
Jessica Garlewicz
Researchers aimed to evaluate how achieving different levels of clinical response or disease activity in patients with nonradiographic (nr-) and radiographic (r-) axial spondyloarthritis.
Researchers aimed to evaluate how achieving different levels of clinical response or disease activity in patients with nonradiographic (nr-) and radiographic (r-) axial spondyloarthritis.
Researchers aimed to evaluate...
05/14/2024
Rheumatology & Arthritis
News
ASAS Issues Consensus Recommendations for Imaging in axSpA
10/10/2024
Rebecca Mashaw
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines...
10/10/2024
Rheumatology & Arthritis
News
Patient-Reported Outcomes in Ankylosing Spondylitis Correlate With Work Productivity
02/26/2024
Jolynn Tumolo
Controlling pain and disease activity helps to improve productivity.
Controlling pain and disease activity helps to improve productivity.
Controlling pain and disease...
02/26/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use